Exact Sciences

About:

Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.

Website: https://www.exactsciences.com

Twitter/X: exactsciences

Top Investors: Excel Venture Management

Description:

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

Total Funding Amount:

$2.75B

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

1995-01-01

Founders:

Anthony P. Shuber, Noubar Afeyan, Stanley Lapidus

Number of Employees:

501-1000

Last Funding Date:

2024-04-11

IPO Status:

Public

© 2025 bioDAO.ai